NUTM1 and nut midline carcinoma: By studying samples expressing the variant fusion NSD3–NUTM1, French et al. have shown that a key component of the oncogenic mechanism in the majority, if not all NMC tumors, is the formation of an iBET-sensitive complex involving NSD3, BRD4 and NUTM1 [14].